Health Catalyst
HCAT
145 hedge funds and large institutions have $204M invested in Health Catalyst in 2025 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 55 increasing their positions, 45 reducing their positions, and 31 closing their positions.
22% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 45
2.06% more ownership
Funds ownership: 75.74% → 77.81% (+2.1%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
12% less funds holding
Funds holding: 165 → 145 (-20)
15% less capital invested
Capital invested by funds: $241M → $204M (-$36.7M)
50% less call options, than puts
Call options by funds: $302K | Put options by funds: $609K
55% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 31
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WCA
Whetstone Capital Advisors
Shawnee Mission,
Kansas
|
+$7.97M |
| 2 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$7.05M |
| 3 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
+$2.61M |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$1.46M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$919K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$9.45M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
-$1.84M |
| 3 |
Millennium Management
New York
|
-$1.72M |
| 4 |
NI
Nepsis Inc
Minneapolis,
Minnesota
|
-$1.44M |
| 5 |
D.E. Shaw & Co
New York
|
-$945K |
HCAT Hedge Fund Activity: Q2 2025 in Review
145 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Health Catalyst (HCAT) for Q2 2025, worth a combined $204M — down 15% from $241M a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of HCAT and 14 opened new positions — a net loss of 17 holders — while 45 trimmed existing stakes and 55 added.
The largest buyer was Whetstone Capital Advisors, adding an estimated $7.97M. The largest seller was Wellington Management Group, exiting entirely with an estimated $9.45M sold.
- 145 institutional investors held Health Catalyst (HCAT) as of Q2 2025, down from 165 in Q1 2025.
- Funds reported $204M of Health Catalyst stock for Q2 2025, down 15% quarter-over-quarter.
- 14 funds opened new Health Catalyst positions in Q2 2025 and 31 closed out, a net change of -17 holders.
- The largest Health Catalyst buyer in Q2 2025 was Whetstone Capital Advisors, an estimated $7.97M added.
- The largest Health Catalyst seller in Q2 2025 was Wellington Management Group, an estimated $9.45M sold.
Based on aggregated 13F filings for Q2 2025.